Cystic fibrosis and inflammation

Number of Honour Places Available
1
Primary Supervisor Email Number Webpage
Dr Elena Schneider-Futschik elena.schneider@unimelb.edu.au Personal web page

Summary The Cystic Fibrosis Pharmacology group is are interested in the mechanisms of drug action, drug-drug interactions and drug safety of cystic fibrosis drugs during pregnancy and breastfeeding.

Project Details

The Cystic Fibrosis Pharmacology group is are interested in the mechanisms of drug action, drug-drug interactions and drug safety of cystic fibrosis drugs during pregnancy and breastfeeding. 

 In this study, we will correlate the functional manifestations of cystic fibrosis with pathological changes in histopathology; and investigate whether administration of ivacaftor, the first CF gene modulator that has significantly improved the life of patients with CF; is beneficial in improving inflammation. 




Key Contact

For further information about this research, please contact a supervisor.


MDHS Research library
Explore by researcher, school, project or topic.